Last reviewed · How we verify
Canadian Forces Health Services Centre Ottawa — Portfolio Competitive Intelligence Brief
0 marketed
0 filed
2 Phase 3
1 Phase 2
0 Phase 1
Live · 30-min refresh
Portfolio leaders (marketed + Phase 3 / filed)
| Drug | Generic | Phase | Class | Target | Area | First approval |
|---|---|---|---|---|---|---|
| Nerve Injection- Nerve Stimulator | Nerve Injection- Nerve Stimulator | phase 3 | Neurology | |||
| Nerve Injection - Ultrasound | Nerve Injection - Ultrasound | phase 3 | Pain Management / Regional Anesthesia |
Therapeutic area mix
- Neurology · 1
- Other · 1
- Pain Management / Regional Anesthesia · 1
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Competitive overlap (companies sharing drug classes)
Subscribe to ongoing alerts
Every new pipeline event for Canadian Forces Health Services Centre Ottawa:
- Canadian Forces Health Services Centre Ottawa pipeline updates — RSS
- Canadian Forces Health Services Centre Ottawa pipeline updates — Atom
- Canadian Forces Health Services Centre Ottawa pipeline updates — JSON
Cite this brief
Drug Landscape (2026). Canadian Forces Health Services Centre Ottawa — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/canadian-forces-health-services-centre-ottawa. Accessed 2026-05-17.